Rein Therapeutics secures third $1 million advance from Yorkville under financing deal

Rein Therapeutics has successfully secured a third $1 million advance from Yorkville as part of their ongoing financing deal. This funding is crucial for the company as it allows them to continue their innovative work in the therapeutic space, potentially leading to significant advancements in treatment options. The support from Yorkville not only boosts Rein's financial stability but also reflects confidence in their future prospects.